We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App





New COVID-19 Test to Scan Saliva or Nasal Swabs Using Specialized Probes for Detecting SARS-CoV-2 RNA Sequences

By HospiMedica International staff writers
Posted on 25 Feb 2021
Print article
Image: Probes and magnetic beads capture RNA related to SARS-CoV-2 (Photo courtesy of Johns Hopkins Medicine)
Image: Probes and magnetic beads capture RNA related to SARS-CoV-2 (Photo courtesy of Johns Hopkins Medicine)
A newly-developed test has the ability to analyze and detect the many subtle changes that can occur in the SARS-CoV-2 viral genome - so-called variants, such as those first identified in the UK and South Africa.

The technique, being developed by researchers at Johns Hopkins Medicine (Baltimore, MD, USA), scans biological specimens, including saliva or nasal swabs, using specialized DNA probes that sift through a complex “forest” of RNA sequences. The probes can detect specific RNA sequences of viruses and other disease-causing pathogens. The team has named their test “cRASL-seq” (pronounced krazzle-seek) which stands for capture RNA-mediated oligonucleotide annealing selection and ligation with next generation DNA sequencing.

The cRASL-seq test uses DNA sequencing instruments, which are able to analyze hundreds to thousands of samples at a time. Each test can detect not only SARS-CoV-2, but many other infectious organisms, say the scientists. Additionally, cRASL-seq skips a step that is required with most of the currently available tests for SARS-CoV-2. Most tests rely on RNA purification kits, which have often been in short supply, hampering efforts to test large swaths of people. The new test does not rely on such purification kits. Rather, it uses specific probes and magnetic beads to capture target RNA at the same time that the detection probes are binding to the viral RNA. The team is continuing to improve the cRASL-seq technology, expanding the test to detect additional organisms and new SARS-CoV-2 variants as they emerge.

“Detecting and tracking the genetic changes associated with these new strains is an enormous priority,” says Ben Larman, Ph.D., assistant professor of pathology and director of the Laboratory of Precision Immunology within the Institute for Cell Engineering at the Johns Hopkins University School of Medicine. “Sequencing instruments are ubiquitous now. This type of laboratory test could be adopted by centers all over the world to detect emerging pathogens and even resistance elements associated with bacterial and fungal infections.”

Related Links:
Johns Hopkins Medicine

Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Silver Member
ECG Management System
NEMS-Q

Print article

Channels

Critical Care

view channel
Image: The permeable wearable electronics developed for long-term biosignal monitoring (Photo courtesy of CityUHK)

Super Permeable Wearable Electronics Enable Long-Term Biosignal Monitoring

Wearable electronics have become integral to enhancing health and fitness by offering continuous tracking of physiological signals over extended periods. This monitoring is crucial for understanding an... Read more

Surgical Techniques

view channel
Image: NTT and Olympus have begun the world\'s first joint demonstration experiment of a cloud endoscopy system (Photo courtesy of Olympus)

Cloud Endoscopy System Enables Real-Time Image Processing on the Cloud

Endoscopes, which are flexible tubes inserted into the body's natural openings for internal examination and biopsy collection, are becoming increasingly vital in medical diagnostics. Their minimal invasiveness... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.